← Dashboard
Oct 27, 2026 10:24 AM ET
Signal
Corporate
Nautilus Biotechnology GAAP EPS of -$0.12 beats by $0.02, revenue of $0.23M beats by $0.02M
Nautilus Biotechnology beat EPS and revenue estimates.
What changed
Nautilus Biotechnology beat EPS and revenue estimates.
Why it matters
Nautilus Biotechnology beat EPS and revenue estimates. — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →
FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →
$FMX →